Emilie M.J. van Brummelen
Emilie M.J. van Brummelen publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Cancer Immunotherapy and Biomarkers, Multiple Myeloma Research and Treatments and Colorectal Cancer Treatments and Studies.
- World rank
- #1,074,756 of 7,710,434 ranked researchers
- Rank in Netherlands
- #24,948 of 107,149
- Works
- 64
- Citations
- 4.8k
- Citations per work
- 74.7
What does Emilie M.J. van Brummelen research?
Emilie M.J. van Brummelen's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2945.8%
- Medicine2945.8%
- Everything else2640.6%
- Life Sciences913.6%
- 1Oncology20% of their works
- 2Molecular Biology14% of their works
- 3Pulmonary and Respiratory Medicine10% of their works
- 4Neurology6% of their works
- 5Hematology5% of their works
- 6Radiology, Nuclear Medicine and Imaging4% of their works
Research topics
Which keywords describe Emilie M.J. van Brummelen's research?
The keywords of their largest research topics: Immune Checkpoint Blockade, PD-1 and PD-L1, Targeted Therapy, Diagnosis Criteria, International Myeloma Working Group, ALK Inhibitors, Cetuximab and EGFR Mutations.
- FGF21
- Skeletal Muscle Atrophy
- Mutational Signatures
- Cancer Genomics
- EGFR Mutations
- ALK Inhibitors
- Diagnosis Criteria
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Targeted Therapy
- International Myeloma Working Group
- Cetuximab
- KRAS Mutations
- Muscle Regeneration
- Parkinson's Disease
- a-Synuclein
- Fibroblast Growth Factor
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Immune Checkpoint Blockade161 topic
- PD-1 and PD-L1161 topic
- Targeted Therapy132 topics
- Diagnosis Criteria91 topic
- International Myeloma Working Group91 topic
- ALK Inhibitors71 topic
- Cetuximab71 topic
- EGFR Mutations71 topic
- KRAS Mutations71 topic
- Cancer Genomics61 topic
- Muscle Regeneration61 topic
- Mutational Signatures61 topic
- Parkinson's Disease61 topic
- Skeletal Muscle Atrophy61 topic
- a-Synuclein61 topic
- FGF2141 topic
- Fibroblast Growth Factor41 topic
Where does Emilie M.J. van Brummelen work?
Emilie M.J. van Brummelen's main affiliation in the publication record is Centre for Human Drug Research, Netherlands.
How many publications and citations does Emilie M.J. van Brummelen have?
OpenAlex counts 64 works and 4,782 citations for Emilie M.J. van Brummelen, an h-index of 22, ranking #1,074,756 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Emilie M.J. van Brummelen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.